Though IFN-γ is linked with COVID-19 severity [50], recent data also suggest that enhanced IFN-γ is associated with the recovery-like stage of these patients with a decreased risk of lung fibrosis [51,52]. The gene discussed is IFNG; the disease is pulmonary fibrosis.